Quick Answer
MAXCYTE, INC. reported Total Assets of $202.51 million for the year ending 2025.
- MAXCYTE, INC. showed a decrease of -15.4% in Total Assets from 2024 to 2025.
- This data is from MAXCYTE, INC.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $93.15 million | Q3 2021: $277.69 million | Q1 2022: $290.96 million | Q2 2022: $289.78 million | Q3 2022: $286.41 million | Q1 2023: $281.54 million | Q2 2023: $271.20 million | Q3 2023: $266.73 million | Q1 2024: $257.93 million | Q2 2024: $251.50 million | Q3 2024: $248.61 million | Q1 2025: $229.96 million | Q2 2025: $219.75 million | Q3 2025: $213.48 million.
- Over the full 6 years of available data (2020 to 2025), MAXCYTE, INC.'s Total Assets has grown by 291.1%.
- Historical annual values: Fiscal year 2025: $202.51 million | Fiscal year 2024: $239.47 million | Fiscal year 2023: $268.27 million | Fiscal year 2022: $286.65 million | Fiscal year 2021: $284.12 million | Fiscal year 2020: $51.78 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: